3 articles tagged with #pharmaceuticals. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
The Trump administration has implemented 100% tariffs on imported pharmaceuticals, creating significant uncertainty around potential EU retaliation. This trade action threatens to disrupt global pharmaceutical supply chains and strain US-EU relations, with broader implications for international commerce and economic stability.
A comprehensive evaluation of Boltz-2, an AI-based drug discovery tool, reveals significant limitations in predicting protein-ligand binding structures and affinities. The study found only weak correlations with physics-based methods and concluded that while useful for initial screening, Boltz-2 lacks the precision required for reliable drug lead identification.
Researchers developed a pharmacology knowledge graph for drug repurposing and found that removing chemical structure representations improved performance while dramatically reducing computational requirements. The study showed that drug behavior can be accurately predicted using only target protein information and network topology, with larger datasets proving more valuable than complex models.
